DEXELANCE SPA (DEX.MI) Fundamental Analysis & Valuation

BIT:DEX • IT0005543480

Current stock price

2.86 EUR
-0.06 (-2.05%)
Last:

This DEX.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. DEX.MI Profitability Analysis

1.1 Basic Checks

  • DEX had negative earnings in the past year.
  • In the past year DEX had a positive cash flow from operations.
  • In multiple years DEX reported negative net income over the last 5 years.
  • In the past 5 years DEX always reported a positive cash flow from operatings.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • DEX has a Return On Assets of -4.07%. This is amonst the worse of the industry: DEX underperforms 82.86% of its industry peers.
  • Looking at the Return On Equity, with a value of -14.86%, DEX is doing worse than 82.86% of the companies in the same industry.
Industry RankSector Rank
ROA -4.07%
ROE -14.86%
ROIC N/A
ROA(3y)2.15%
ROA(5y)1.95%
ROE(3y)5.6%
ROE(5y)4.9%
ROIC(3y)N/A
ROIC(5y)N/A
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10 15

1.3 Margins

  • DEX has a Gross Margin (27.37%) which is in line with its industry peers.
  • DEX's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-10.08%
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. DEX.MI Health Analysis

2.1 Basic Checks

  • DEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, DEX has less shares outstanding
  • DEX has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for DEX is higher compared to a year ago.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • The Debt to FCF ratio of DEX is 38.37, which is on the high side as it means it would take DEX, 38.37 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of DEX (38.37) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.80 indicates that DEX is somewhat dependend on debt financing.
  • The Debt to Equity ratio of DEX (0.80) is worse than 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 38.37
Altman-Z N/A
ROIC/WACCN/A
WACC5.97%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

  • DEX has a Current Ratio of 1.13. This is a normal value and indicates that DEX is financially healthy and should not expect problems in meeting its short term obligations.
  • DEX's Current ratio of 1.13 is on the low side compared to the rest of the industry. DEX is outperformed by 68.57% of its industry peers.
  • A Quick Ratio of 0.77 indicates that DEX may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.77, DEX is in line with its industry, outperforming 51.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.77
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DEX.MI Growth Analysis

3.1 Past

  • DEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.70%.
  • The Revenue has decreased by -4.23% in the past year.
  • Measured over the past years, DEX shows a very strong growth in Revenue. The Revenue has been growing by 23.78% on average per year.
EPS 1Y (TTM)-209.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.11%
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y17.08%
Revenue growth 5Y23.78%
Sales Q2Q%-4.62%

3.2 Future

  • Based on estimates for the next years, DEX will show a decrease in Earnings Per Share. The EPS will decrease by -6.47% on average per year.
  • Based on estimates for the next years, DEX will show a quite strong growth in Revenue. The Revenue will grow by 9.80% on average per year.
EPS Next Y20.14%
EPS Next 2Y12.47%
EPS Next 3Y-6.47%
EPS Next 5YN/A
Revenue Next Year6.67%
Revenue Next 2Y5.46%
Revenue Next 3Y9.8%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

4

4. DEX.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • DEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • DEX is valuated cheaply with a Price/Forward Earnings ratio of 4.94.
  • Based on the Price/Forward Earnings ratio, DEX is valued cheaper than 94.29% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of DEX to the average of the S&P500 Index (38.00), we can say DEX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.94
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • DEX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DEX is more expensive than 74.29% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as DEX.
Industry RankSector Rank
P/FCF 18.47
EV/EBITDA 351.25
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A cheap valuation may be justified as DEX's earnings are expected to decrease with -6.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.47%
EPS Next 3Y-6.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DEX.MI Dividend Analysis

5.1 Amount

  • DEX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DEX.MI Fundamentals: All Metrics, Ratios and Statistics

DEXELANCE SPA

BIT:DEX (4/21/2026, 7:00:00 PM)

2.86

-0.06 (-2.05%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners13.19%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap77.02M
Revenue(TTM)457.75M
Net Income(TTM)-22.19M
Analysts85.71
Price Target8.33 (191.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.49%
PT rev (3m)-6.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.02%
EPS NY rev (3m)-12.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.94
P/S 0.17
P/FCF 18.47
P/OCF 5.02
P/B 0.52
P/tB N/A
EV/EBITDA 351.25
EPS(TTM)-0.84
EYN/A
EPS(NY)0.58
Fwd EY20.22%
FCF(TTM)0.15
FCFY5.41%
OCF(TTM)0.57
OCFY19.9%
SpS17
BVpS5.54
TBVpS-4.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -14.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.37%
FCFM 0.91%
ROA(3y)2.15%
ROA(5y)1.95%
ROE(3y)5.6%
ROE(5y)4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-10.08%
F-Score3
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 38.37
Debt/EBITDA 287.07
Cap/Depr 49.51%
Cap/Sales 2.44%
Interest Coverage N/A
Cash Conversion 3693.73%
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.77
Altman-Z N/A
F-Score3
WACC5.97%
ROIC/WACCN/A
Cap/Depr(3y)40.08%
Cap/Depr(5y)36.04%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.11%
EPS Next Y20.14%
EPS Next 2Y12.47%
EPS Next 3Y-6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y17.08%
Revenue growth 5Y23.78%
Sales Q2Q%-4.62%
Revenue Next Year6.67%
Revenue Next 2Y5.46%
Revenue Next 3Y9.8%
Revenue Next 5YN/A
EBIT growth 1Y-157.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.23%
EBIT Next 3Y30.95%
EBIT Next 5YN/A
FCF growth 1Y-87.24%
FCF growth 3Y-43.61%
FCF growth 5Y-24.56%
OCF growth 1Y-60.86%
OCF growth 3Y-15.86%
OCF growth 5Y-5.5%

DEXELANCE SPA / DEX.MI Fundamental Analysis FAQ

What is the fundamental rating for DEX stock?

ChartMill assigns a fundamental rating of 3 / 10 to DEX.MI.


What is the valuation status for DEX stock?

ChartMill assigns a valuation rating of 5 / 10 to DEXELANCE SPA (DEX.MI). This can be considered as Fairly Valued.


How profitable is DEXELANCE SPA (DEX.MI) stock?

DEXELANCE SPA (DEX.MI) has a profitability rating of 2 / 10.


How sustainable is the dividend of DEXELANCE SPA (DEX.MI) stock?

The dividend rating of DEXELANCE SPA (DEX.MI) is 0 / 10 and the dividend payout ratio is 0%.